ANDA 207843, held by Hisun Pharm Hangzhou. Telmisartan.
As of Nov 14, 2026, ANDA 207843 (Telmisartan), held by Hisun Pharm Hangzhou, was first approved by FDA on Feb 19, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 19, 2019 | Original application | Approved | None posted |
| Telmisartan20MG · tablet;oral | Telmisartan | Discontinued |
| Telmisartan40MG · tablet;oral | Telmisartan | Discontinued |
| Telmisartan80MG · tablet;oral | Telmisartan | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
